A clinical tool for predicting survival in ALS

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 12, 2016, Pages 1361-1367

  Knibb, Jonathan A ^a   Keren, Noa ^b   Kulka, Anna ^b   Leigh, P Nigel ^c   Martin, Sarah ^b   Shaw, Christopher E ^b   Tsuda, Miho ^d   Al Chalabi, Ammar ^b  

^a ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^d MACCLESFIELD DISTRICT GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RILUZOLE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; EFFECT SIZE; ENGLAND; FALLING; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONINVASIVE VENTILATION; POPULATION RESEARCH; PRIORITY JOURNAL; SURVIVAL TIME; AGE; BREATHING MUSCLE; DISEASE COURSE; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOPHYSIOLOGY; REGISTER; SURVIVAL ANALYSIS;

AGE FACTORS; AGED; AMYOTROPHIC LATERAL SCLEROSIS; DISEASE PROGRESSION; ENGLAND; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NONINVASIVE VENTILATION; REGISTRIES; RESPIRATORY MUSCLES; RILUZOLE; SURVIVAL ANALYSIS;

EID: 84979000435     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2015-312908     Document Type: Article

References (30)

1. Johnston CA, Stanton BR, Turner MR, et al. Amyotrophic lateral sclerosis in an urban setting: a population based study of inner city London. J Neurol 2006;253:1642-3.
2. Al-Chalabi A, Fang F, Hanby MF, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry 2010;81:1324-6.
3. Chiò A, Logroscino G, Hardiman O, et al. Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009;10:310-23.
4. Wei Q, Chen X, Zheng Z, et al. The predictors of survival in Chinese amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:237-44.
5. Javad Mousavi SA, Zamani B, Shahabi Shahmiri S, et al. Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival. Iran J Neurol 2014;13:131-7.
6. Wolf J, Safer A, Wöhrle JC, et al. Factors predicting one-year mortality in amyotrophic lateral sclerosis patients-data from a population-based registry. BMC Neurol 2014;14:197.
7. Pupillo E, Messina P, Logroscino G, et al. Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 2014;75:287-97.
8. Pinto S, Pinto A, de Carvalho M. Phrenic nerve studies predict survival in amyotrophic lateral sclerosis. Clin Neurophysiol 2012;123:2454-9.
9. Elamin M, Phukan J, Bede P, et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology 2011;76:1263-9.
10. Rooney J, Byrne S, Heverin M, et al. Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010. PLoS ONE 2013;8:e74733.
11. Elamin M, Bede P, Montuschi A, et al. Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol 2015;262:1447-54.
12. Talman P, Forbes A, Mathers S. Clinical phenotypes and natural progression for motor neuron disease: analysis from an Australian database. Amyotroph Lateral Scler 2009;10:79-84.
13. Abhinav K, Stanton B, Johnston C, et al. Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology 2007;29:44-8.
14. Gil J, Funalot B, Verschueren A, et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study. Eur J Neurol 2008;15:1245-51.
15. Kurian KM, Forbes RB, Colville S, et al. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. J Neurol Neurosurg Psychiatry 2009;80:84-7.
16. Spataro R, Lo Re M, Piccoli T, et al. Causes and place of death in Italian patients with amyotrophic lateral sclerosis. Acta Neurol Scand 2010;122:217-23.
17. Yang R, Huang R, Chen D, et al. Causes and places of death of patients with amyotrophic lateral sclerosis in south-west China. Amyotroph Lateral Scler 2011;12:206-9.
18. Furukawa Y, Komai M, Ishida C, et al. Cause of death in Japanese patients with amyotrophic lateral sclerosis on tracheostomy-positive pressure ventilation. Eur Neurol 2012;68:261-3.
19. Tsai C, Chang B, Lee C. Underlying cause and place of death among patients with amyotrophic lateral sclerosis in Taiwan: a population-based study, 2003-2008. J Epidemiol 2013;23:424-8.
20. Brooks B, Miller R, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293-9.
21. Bourke SC, Tomlinson M, Williams TL, et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5:140-7.
22. Wijesekera LC, Mathers S, Talman P, et al. Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 2009;72:1087-94.
23. Millul A, Beghi E, Logroscino G, et al. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Neuroepidemiology 2005;25: 114-19.
24. Uebayashi Y, Yase Y, Tanaka H, et al. Prognosis of motor neuron disease in Japan. Neuroepidemiology 1983;2:243-56.
25. Olney RK, Murphy J, Forshew D, et al. The effects of executive and behavioral dysfunction on the course of ALS. Neurology 2005;65:1774-7.
26. Nakamura R, Atsuta N, Watanabe H, et al. Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 2013;84:1365-71.
27. Byrne S, Elamin M, Bede P, et al. Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 2012;11:232-40.
28. Diekstra FP, van Deerlin VM, van Swieten JC, et al. C9orf72 and UNC13A are shared risk loci for amyotrophic lateral sclerosis and frontotemporal dementia: a genome-wide meta-analysis. Ann Neurol 2014;76:120-33.
29. Rooney J, Byrne S, Heverin M, et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychiatry 2015;86:496-501.
30. Marin B, Logroscino G, Boumédiene F, et al. Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol 2016;31:229-45.